# Vitrectomy for Epiretinal Membrane Peeling in Patients with Diabetic Retinopathy—Functional and Morphological Outcome

## TL;DR

This study examines the outcomes of vitrectomy with membrane peeling for diabetic retinopathy, finding anatomical improvements but limited visual gains.

## Contribution

Provides new evidence on anatomical outcomes of ERM peeling in diabetic retinopathy patients.

## Key findings

- Significant reductions in retinal thickness and macular volume after surgery.
- Limited improvement in visual acuity despite anatomical improvements.
- Low recurrence rate and absence of major complications.

## Abstract

Background: Secondary epiretinal membrane (ERM) is a common complication of diabetic retinopathy, but data on surgical outcome is limited. The aim of this study was to evaluate anatomical and functional outcomes after pars plana vitrectomy with ERM peeling in eyes with diabetic retinopathy. Methods: A retrospective analysis was conducted on 87 eyes of 87 consecutive patients with diabetic retinopathy who underwent ERM peeling over a ten-year period (04/2013–11/2022). Collected data included demographics, best-corrected visual acuity (BCVA), stage of diabetic retinopathy, and optical coherence tomography parameters such as central subfield retinal thickness (CSRT), macular volume (MV), and presence of hyperreflective foci, subretinal fluid, and intraretinal fluid. Statistical analyses were performed using a paired t-test and the Wilcoxon test. Results: The majority of patients had type 2 diabetes (96.6%), and 69.0% presented with diabetic macular edema (DME). The mean follow-up was 2.2 ± 2.0 years. Significant postoperative reductions were observed in CSRT (from 377.20 ± 99.28 µm to 337.99 ± 113.834 µm; p = 0.008) and MV (from 10.11 ± 1.46 mm3 to 99.28 ± 1.07 mm3; p < 0.001). No significant changes in BCVA were observed across the entire study cohort. ERM recurrence was rare (2.3%), and no major complications occurred. Conclusions: ERM peeling in diabetic eyes leads to significant anatomical improvement, especially in advanced diabetic retinopathy and DME, but with limited functional gains. The surgical indication should be carefully considered.